TOKYO--(BUSINESS WIRE)--Modulus Discovery, Inc., a preclinical-stage computation-driven drug discovery firm, announces the successful closing of its Series C funding round in the amount of 2.34B JPY ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Williamson has served as the CEO and partner of Modulus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results